Study to Assess the Safety and Tolerability of Multiple Ascending Doses of REGN1500
Clinical trial NCT02107872 · COMPLETED
Trial details
- NCT number
- NCT02107872
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2015-09-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.